Lymphoid priming in human bone marrow begins before expression of CD10 with upregulation of L-selectin

Authors:

Abstract
'Lymphoid priming' in human bone marrow is traditionally thought to begin with the expression of CD10 on CD34+ progenitors. Crooks and colleagues now demonstrate lymphoid priming in a subset of CD10–CD34+ progenitors that are CD62Lhi. Expression of the cell-surface antigen CD10 has long been used to define the lymphoid commitment of human cells. Here we report a unique lymphoid-primed population in human bone marrow that was generated from hematopoietic stem cells (HSCs) before onset of the expression of CD10 and commitment to the B cell lineage. We identified this subset by high expression of the homing molecule L-selectin (CD62L). CD10−CD62Lhi progenitors had full lymphoid and monocytic potential but lacked erythroid potential. Gene-expression profiling placed the CD10−CD62Lhi population at an intermediate stage of differentiation between HSCs and lineage-negative (Lin−) CD34+CD10+ progenitors. CD62L was expressed on immature thymocytes, and its ligands were expressed at the cortico-medullary junction of the thymus, which suggested a possible role for this molecule in homing to the thymus. Our studies identify the earliest stage of lymphoid priming in human bone marrow.

This publication has 50 references indexed in Scilit: